Methylenetetrahydrofolate reductase gene C677T polymorphism and lung cancer: An updated meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2025-2029

  Hou, Xin Heng ^a   Huang, Yu Min ^b   Mi, Yuan Yuan ^c  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Lung cancer; Meta analysis; MTHFR; Polymorphism

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; META ANALYSIS; PROGNOSIS; RISK FACTOR;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SMALL CELL LUNG CARCINOMA;

EID: 84872678661     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2025     Document Type: Article

References (38)

1. Arslan S, Karadayi S, Yildirim ME, et al (2011). The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep, 38, 991-6.
2. Bandera EV, Freudenheim JL, Marshall JR, et al (1997). Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control, 8, 828-40.
3. Boccia S, Boffetta P, Brennan P, et al (2009). Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett, 273, 55-61.
4. Cui LH, Shin MH, Kim HN, et al (2011). Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet, 12, 28.
5. Cui LH, Yu Z, Zhang TT, et al (2011). Influence of polymorphisms in MTHFR 677 CgT, TYMS 3Rg2R and MTR 2756 AgG on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Pharmacogenomics, 12, 797-808.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
7. Egger M, Davey Smith G, Schneider M (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
9. Guan P, Huang D, Yin Z, et al (2011). Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac J Cancer Prev, 12, 1067-72.
10. Heijmans BT, Boer JM, Suchiman HE, et al (2003). A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res, 63, 1249-53.
11. Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis, 28, 1334-40.
12. Jacques PF, Bostom AG, Williams RR, et al (1996). Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 93, 7-9.
13. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
14. Jeng YL, Wu MH, Huang HB, et al (2003). The methylenetetrahydrofolate reductase 677C→T polymorphism and lung cancer risk in a Chinese population. Anticancer Res, 23, 5149-52.
15. Krajinovic M, Lamothe S, Labuda D, et al (2004). Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood, 103, 252-7.
16. Liao SG, Liu L, Zhang YY, et al (2012). SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 579-83.
17. Liu CS, Tsai CW, Hsia TC, et al (2009). Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics, 6, 325-9.
18. Liu H, Jin G, Wang H, et al (2008). Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer, 61, 21-9.
19. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
20. Mao R, Fan Y, Jin Y, et al (2008). Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J Hum Genet, 53, 340-8.
21. Mattson ME, Pollack ES, Cullen JW (1987). What are the odds that smoking will kill you. Am J Public Health, 77, 425-31.
22. Muslumanoglu MH, Tepeli E, Demir S, et al (2009). The analysis of the relationship between A1298C and C677T polymorphisms of the MTHFR gene with prostate cancer in Eskisehir population. Genet Test Mol Biomarkers, 13, 641-5.
23. Pan F, Tian J, Pan Y, et al (2011). Lack of association of the cyclooxygenase 8473 T>C polymorphism with lung cancer: evidence from 9841 subjects. Asian Pac J Cancer Prev, 12, 1941-5.
24. Schabath MB, Spitz MR, Lerner SP, et al (2005). Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer, 53, 144-51.
25. Shen H, Spitz MR, Wang LE, et al (2001). Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev, 10, 397-401.
26. Shen H, Wei Q, Pillow PC, et al (2003). Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev, 12, 980-6.
27. Shen M, Rothman N, Berndt SI, et al (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer, 49, 299-309.
28. Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene, 21, 6870-6.
29. Shields PG, Harris CC (2000). Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol, 18, 2309-15. Shi Q, Zhang Z, Li G, et al (2005). Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev, 14, 1477-84.
30. Shi Q, Zhang Z, Li G, et al (2005). Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev, 14, 1477-84.
31. Shrubsole MJ, Gao YT, Cai Q, et al (2004). MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev, 13, 190-6.
32. Siemianowicz K, Gminski J, Garczorz W, et al (2003). Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol Rep, 10, 1341-4.
33. Spitz MR, Wei Q, Dong Q, et al (2003). Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev, 12, 689-98.
34. Suzuki T, Matsuo K, Hiraki A, et al (2007). Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis, 28, 1718-25.
35. Voorrips LE, Goldbohm RA, Brants HA, et al (2000). A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 357-65.
36. Xiao H, Ding J, Gao S, et al (2011). Never smokers with lung cancer: analysis of genetic variants. Asian Pac J Cancer Prev, 12, 2807-9.
37. Xu WH, Shrubsole MJ, Xiang YB, et al (2007). Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev, 16, 281-7.
38. Zhang XM, Miao XP, Tan W, et al (2005). Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 27, 700-73